[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Weight Loss Drugs-North America Market Status and Trend Report 2013-2023

February 2018 | 147 pages | ID: W7B9DC85A1EMEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Weight Loss Drugs-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Weight Loss Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole North America and Regional Market Size of Weight Loss Drugs 2013-2017, and development forecast 2018-2023
Main market players of Weight Loss Drugs in North America, with company and product introduction, position in the Weight Loss Drugs market
Market status and development trend of Weight Loss Drugs by types and applications
Cost and profit status of Weight Loss Drugs, and marketing status
Market growth drivers and challenges

The report segments the North America Weight Loss Drugs market as:

North America Weight Loss Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

United States
Canada
Mexico

North America Weight Loss Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Liauid
Tablets

North America Weight Loss Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Weight-reducing Aid
Other

North America Weight Loss Drugs Market: Players Segment Analysis (Company and Product introduction, Weight Loss Drugs Sales Volume, Revenue, Price and Gross Margin):

Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Zein Pharmaceutical
Hisun
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
Dm Pharma
China Zhongshan Pharm

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF WEIGHT LOSS DRUGS

1.1 Definition of Weight Loss Drugs in This Report
1.2 Commercial Types of Weight Loss Drugs
  1.2.1 Liauid
  1.2.2 Tablets
1.3 Downstream Application of Weight Loss Drugs
  1.3.1 Weight-reducing Aid
  1.3.2 Other
1.4 Development History of Weight Loss Drugs
1.5 Market Status and Trend of Weight Loss Drugs 2013-2023
  1.5.1 North America Weight Loss Drugs Market Status and Trend 2013-2023
  1.5.2 Regional Weight Loss Drugs Market Status and Trend 2013-2023

CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Weight Loss Drugs in North America 2013-2017
2.2 Consumption Market of Weight Loss Drugs in North America by Regions
  2.2.1 Consumption Volume of Weight Loss Drugs in North America by Regions
  2.2.2 Revenue of Weight Loss Drugs in North America by Regions
2.3 Market Analysis of Weight Loss Drugs in North America by Regions
  2.3.1 Market Analysis of Weight Loss Drugs in United States 2013-2017
  2.3.2 Market Analysis of Weight Loss Drugs in Canada 2013-2017
  2.3.3 Market Analysis of Weight Loss Drugs in Mexico 2013-2017
2.4 Market Development Forecast of Weight Loss Drugs in North America 2018-2023
  2.4.1 Market Development Forecast of Weight Loss Drugs in North America 2018-2023
  2.4.2 Market Development Forecast of Weight Loss Drugs by Regions 2018-2023

CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole North America Market Status by Types
  3.1.1 Consumption Volume of Weight Loss Drugs in North America by Types
  3.1.2 Revenue of Weight Loss Drugs in North America by Types
3.2 North America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in United States
  3.2.2 Market Status by Types in Canada
  3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Weight Loss Drugs in North America by Types

CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Weight Loss Drugs in North America by Downstream Industry
4.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Weight Loss Drugs by Downstream Industry in United States
  4.2.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Canada
  4.2.3 Demand Volume of Weight Loss Drugs by Downstream Industry in Mexico
4.3 Market Forecast of Weight Loss Drugs in North America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF WEIGHT LOSS DRUGS

5.1 North America Economy Situation and Trend Overview
5.2 Weight Loss Drugs Downstream Industry Situation and Trend Overview

CHAPTER 6 WEIGHT LOSS DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA

6.1 Sales Volume of Weight Loss Drugs in North America by Major Players
6.2 Revenue of Weight Loss Drugs in North America by Major Players
6.3 Basic Information of Weight Loss Drugs by Major Players
  6.3.1 Headquarters Location and Established Time of Weight Loss Drugs Major Players
  6.3.2 Employees and Revenue Level of Weight Loss Drugs Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 WEIGHT LOSS DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Roche
  7.1.1 Company profile
  7.1.2 Representative Weight Loss Drugs Product
  7.1.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche
7.2 GSK group
  7.2.1 Company profile
  7.2.2 Representative Weight Loss Drugs Product
  7.2.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group
7.3 Teva
  7.3.1 Company profile
  7.3.2 Representative Weight Loss Drugs Product
  7.3.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva
7.4 Sandoz(Novartis)
  7.4.1 Company profile
  7.4.2 Representative Weight Loss Drugs Product
  7.4.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis)
7.5 STADA-VN J.V.Co., Ltd
  7.5.1 Company profile
  7.5.2 Representative Weight Loss Drugs Product
  7.5.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd
7.6 Hexal AG
  7.6.1 Company profile
  7.6.2 Representative Weight Loss Drugs Product
  7.6.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG
7.7 National Company For Pharmaceutical Industry
  7.7.1 Company profile
  7.7.2 Representative Weight Loss Drugs Product
  7.7.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry
7.8 Lunan Pharmaceutical Group Corporation
  7.8.1 Company profile
  7.8.2 Representative Weight Loss Drugs Product
  7.8.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation
7.9 Zein Pharmaceutical
  7.9.1 Company profile
  7.9.2 Representative Weight Loss Drugs Product
  7.9.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical
7.10 Hisun
  7.10.1 Company profile
  7.10.2 Representative Weight Loss Drugs Product
  7.10.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun
7.11 Taj Pharmaceuticals Ltd
  7.11.1 Company profile
  7.11.2 Representative Weight Loss Drugs Product
  7.11.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd
7.12 Kabir Life Sciences & Research
  7.12.1 Company profile
  7.12.2 Representative Weight Loss Drugs Product
  7.12.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research
7.13 Dm Pharma
  7.13.1 Company profile
  7.13.2 Representative Weight Loss Drugs Product
  7.13.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma
7.14 China Zhongshan Pharm
  7.14.1 Company profile
  7.14.2 Representative Weight Loss Drugs Product
  7.14.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF WEIGHT LOSS DRUGS

8.1 Industry Chain of Weight Loss Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF WEIGHT LOSS DRUGS

9.1 Cost Structure Analysis of Weight Loss Drugs
9.2 Raw Materials Cost Analysis of Weight Loss Drugs
9.3 Labor Cost Analysis of Weight Loss Drugs
9.4 Manufacturing Expenses Analysis of Weight Loss Drugs

CHAPTER 10 MARKETING STATUS ANALYSIS OF WEIGHT LOSS DRUGS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications